Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Kintor Pharmaceutical Ltd ( (HK:9939) ) is now available.
Kintor Pharmaceutical Limited has announced a board meeting scheduled for August 28, 2025, to consider and approve the interim results for the first half of the year ending June 30, 2025. This meeting is significant as it will provide insights into the company’s financial performance and strategic direction, impacting stakeholders and potentially influencing its market positioning.
More about Kintor Pharmaceutical Ltd
Kintor Pharmaceutical Limited is a company incorporated in the Cayman Islands, operating within the pharmaceutical industry. It focuses on the development and commercialization of innovative therapies, particularly in the areas of oncology and dermatology.
Average Trading Volume: 6,577,508
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.06B
For detailed information about 9939 stock, go to TipRanks’ Stock Analysis page.